Valuation: REMSleep Holdings, Inc.

Market Cap 2.69M 2.39M 2.24M 2.04M 3.84M 259M 3.89M 27.05M 10.47M 132M 10.11M 9.89M 424M P/E 2024
-11.4x
P/E 2025 -0.88x
Enterprise Value 2.56M 2.27M 2.12M 1.93M 3.64M 246M 3.69M 25.69M 9.94M 125M 9.6M 9.39M 403M EV / Sales 2024
104,179,528x
EV / Sales 2025 157,471,623x
Free-Float
97.92%
Yield 2024 *
-
Yield 2025 -
1 week-6.25%
1 month-18.92%
3 months-54.55%
6 months-77.78%
Current year-11.76%
1 week 0
Extreme 0.0011
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.03
5 years 0
Extreme 0.0011
0.04
10 years 0
Extreme 0.0011
35
Manager TitleAgeSince
Chief Executive Officer - 27/05/2026
Treasurer 78 27/05/2026
President - 02/06/2026
Director TitleAgeSince
Director/Board Member 52 02/03/2026
Chairman 78 27/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-6.25%-53.70%-90.00% 2.69M
-2.17%-4.33%-27.56%-0.17% 167B
+0.17%-2.34%-8.83%+10.31% 111B
-0.88%+1.19%-25.04%-0.11% 105B
+0.93%+1.42%-47.91%-10.82% 74.82B
+3.17%-0.03%-0.64%+72.13% 59.11B
-0.86%+2.96%+13.57%+59.50% 51.8B
-0.52%-0.65%-6.74%-31.12% 48.5B
-0.85%+0.85%-16.51%+18.41% 40.79B
-0.07%-1.42%+30.49%-7.58% 32.54B
Average -0.11%-0.77%-14.29%+2.05% 69.02B
Weighted average by Cap. -0.41%-0.91%-16.14%+9.61%

Financials

2024 2025
Net sales 0.12 0.1 0.1 0.09 0.17 11.28 0.17 1.18 0.46 5.75 0.44 0.43 18.46 0.02 0.01 0.01 0.01 0.02 1.61 0.02 0.17 0.07 0.82 0.06 0.06 2.63
Net income -1.08M -957K -895K -816K -1.54M -104M -1.56M -10.83M -4.19M -52.86M -4.05M -3.96M -170M -3.02M -2.68M -2.51M -2.29M -4.3M -291M -4.36M -30.35M -11.75M -148M -11.34M -11.09M -476M
Net Debt -438K -389K -364K -331K -624K -42.15M -632K -4.4M -1.7M -21.47M -1.64M -1.61M -68.95M -136K -121K -113K -103K -194K -13.1M -197K -1.37M -529K -6.67M -511K -500K -21.44M
Logo REMSleep Holdings, Inc.
REMSleep Holdings, Inc. is a medical device manufacturer. The Company’s focus is primarily on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. Its patented DeltaWave product is a nasal-pillow type interface that is designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. DeltaWave delivers comfort and airflow for better sleep and improved CPAP therapy. The Company’s product is manufactured by mold makers. It has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.
Employees
-
Date Price Change Volume
01/10/26 $0.001500 0.00% 3,474,955
30/09/26 $0.001500 +15.38% 5,802,600
29/09/26 $0.001300 -7.14% 468,537
28/09/26 $0.001400 -6.67% 423,652
25/09/26 $0.001500 -6.25% 282,122
  1. Stock Market
  2. Stocks
  3. RMSL Stock